<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Topics tagged with ipamorelin]]></title><description><![CDATA[A list of topics that have been tagged with ipamorelin]]></description><link>https://community.peptidecritic.com/tags/ipamorelin</link><generator>RSS for Node</generator><lastBuildDate>Sat, 04 Apr 2026 08:26:09 GMT</lastBuildDate><atom:link href="https://community.peptidecritic.com/tags/ipamorelin.rss" rel="self" type="application/rss+xml"/><pubDate>Invalid Date</pubDate><ttl>60</ttl><item><title><![CDATA[CJC-1295 WITH DAC Regimen]]></title><description><![CDATA[I know who AlphaBiomed is….T clinics are making him very, very rich.
]]></description><link>https://community.peptidecritic.com/topic/480/cjc-1295-with-dac-regimen</link><guid isPermaLink="true">https://community.peptidecritic.com/topic/480/cjc-1295-with-dac-regimen</guid><dc:creator><![CDATA[ResearchCat]]></dc:creator><pubDate>Invalid Date</pubDate></item><item><title><![CDATA[Sermorelin Research Dosing Protocol]]></title><description><![CDATA[I know sermorelin is FDA approved and very safe. I researched it for a few months when I started this adventure. I have to say results are subtle at best. As compared with CJC/Ipamorelin, which is more like a shotgun. FWIW, my sermorelin research was in line with the prescriber’s recommendation, while CJC/Ipamorelin was inline with common protocols(200-300mcg/day).
I don’t completely dismiss it the way a lot of YouTubers do, but for researchers who can tolerate it and are less patient, it seems most of the other GHRH peptides give more noticeable results faster.
]]></description><link>https://community.peptidecritic.com/topic/341/sermorelin-research-dosing-protocol</link><guid isPermaLink="true">https://community.peptidecritic.com/topic/341/sermorelin-research-dosing-protocol</guid><dc:creator><![CDATA[ResearchCat]]></dc:creator><pubDate>Invalid Date</pubDate></item><item><title><![CDATA[CJC-1295 NO DAC (Mod GRF 1–29) Research Dosing Protocol]]></title><description><![CDATA[She's the real deal. The only thing id add is to research them separately first. Reactions to cjc arent rare and ipa does happen. Its best to know which one if you were to have a bad time.
]]></description><link>https://community.peptidecritic.com/topic/340/cjc-1295-no-dac-mod-grf-1-29-research-dosing-protocol</link><guid isPermaLink="true">https://community.peptidecritic.com/topic/340/cjc-1295-no-dac-mod-grf-1-29-research-dosing-protocol</guid><dc:creator><![CDATA[Randy]]></dc:creator><pubDate>Invalid Date</pubDate></item><item><title><![CDATA[Ipamorelin — Subcutaneous Research Dosing Protocol]]></title><description><![CDATA[@Randy It’s funny; a friend of mine is on reta and like it a lot but is increasing his dose because of food noise/hunger. I use tirz and he keeps trying to get me to move to reta but I am not having trouble with food noise on a very low dose.
Hence why I always say to take it slow and see what works best for you. Maybe I will try reta at some point, but right now I see no reason to mess with variables that aren’t causing problems.
]]></description><link>https://community.peptidecritic.com/topic/339/ipamorelin-subcutaneous-research-dosing-protocol</link><guid isPermaLink="true">https://community.peptidecritic.com/topic/339/ipamorelin-subcutaneous-research-dosing-protocol</guid><dc:creator><![CDATA[ResearchCat]]></dc:creator><pubDate>Invalid Date</pubDate></item></channel></rss>